Elbert Huang to Cost-Benefit Analysis
This is a "connection" page, showing publications Elbert Huang has written about Cost-Benefit Analysis.
Connection Strength
2.280
-
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
Score: 0.388
-
The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Aliment Pharmacol Ther. 2007 Oct 15; 26(8):1147-61.
Score: 0.258
-
The Economic Evaluation of Team Clinic-Group Approach to a Care Model of Early Adolescents With Type 1 Diabetes. J Pediatr Health Care. 2022 Sep-Oct; 36(5):430-437.
Score: 0.179
-
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 08; 162(2):249-255.
Score: 0.166
-
Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial. Diabetes Care. 2019 08; 42(8):1589-1592.
Score: 0.145
-
Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 2018 11; 38(8):942-953.
Score: 0.139
-
Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06; 41(6):1227-1234.
Score: 0.133
-
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
Score: 0.130
-
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.
Score: 0.081
-
The public health implications of the cost-effectiveness of bariatric surgery for diabetes. Diabetes Care. 2010 Sep; 33(9):2126-8.
Score: 0.079
-
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2010 Jun; 33(6):1269-74.
Score: 0.076
-
JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008 Aug; 10(4):310-21.
Score: 0.068
-
The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res. 2007 Dec; 42(6 Pt 1):2174-93; discussion 2294-323.
Score: 0.065
-
Estimating costs of quality improvement for outpatient healthcare organisations: a practical methodology. Qual Saf Health Care. 2007 Aug; 16(4):248-51.
Score: 0.064
-
The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006 Feb; 29(2):259-64.
Score: 0.057
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
Score: 0.045
-
Cost and healthcare utilization analysis of culturally sensitive, shared medical appointment model for Latino children with type 1 diabetes. Pediatr Diabetes. 2021 08; 22(5):816-822.
Score: 0.041
-
Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021 09; 128:108262.
Score: 0.040
-
Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. Am J Gastroenterol. 2021 01 01; 116(1):125-133.
Score: 0.040
-
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
Score: 0.037
-
Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
Score: 0.027
-
Health utilities for children and adults with type 1 diabetes. Med Care. 2011 Oct; 49(10):924-31.
Score: 0.021